experts speculate that the natural expiration of the early adopter wave and growing privacy concerns are to blame. But companies might be able to recover if they provide compelling medical reasons for users to get the tests.
from Tech https://ift.tt/2Zndhpa
Subscribe to:
Post Comments (Atom)
-
AMD Zen 2 processors are practically around the corner, and so is Ryzen’s next-generation X570 chipset platform, apparently. Instead of the...
-
Mechanical upgrades, interior updates and a host of driver-assistance technology make the Type R more appealing than ever. from CNET News ...
No comments:
Post a Comment